Evaluation of Effectiveness of Selected Physical and Kinesiotherapeutic Methods in Patients With Lower Calcaneal Spur

NCT ID: NCT02934100

Last Updated: 2016-10-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-08-31

Study Completion Date

2018-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluates the effectiveness of physiotherapy and kinesiotherapy in patients with calcaneal spurs. the aim of the study is to compare the efficacy of calcaneal spurs treatment provided with extracorporeal shock wave therapy, ultrasound therapy, electric field diathermy associated with kinesiotherapy and sham laser in combination with kinesiotherapy. In each group kinesiotherapy treatment is the same and consists of an eight-minute massage of posterior lower leg muscles and plantar aponeurosis stretching.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Number of 120 diagnosed with heel spur patients, will be allocated randomly into one of three treatment groups or into the control group. Assignment to a group is random, but before that happens patients will be questioned about inclusion and exclusion criteria of the study. Depending on group allocation, patients in treatment groups will receive one of the following physical therapy treatments:

* ESWT (once a week for 10 weeks)
* ultrasound (three times a week for 5 weeks)
* electric field diathermy (three times a week for 5 weeks).

Patients allocated in control group, will receive a sham laser therapy (only the timer on the machine activated) three times a week for 5 weeks.

Regardless of affiliation to the group, each patient will also receive kinesiotherapy treatment.

At the beginning of the study, each patient receives the "Information for the patient," describing the exact course of each stage of the study, then signs a "Form of informed consent to participate in the study.". The next stage of the study is to fill in the participant survey questionnaire and physical examination provided by the researcher.

Assessment of improvements will be made twice: right after the therapy and two months later. Every stage of the study is carried out by one and the same investigator.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heel Spur Calcaneal Spur

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1 - ESWT Treatment

Patients treated with Extracorporeal Shock Wave Therapy once a week for 10 weeks

Group Type ACTIVE_COMPARATOR

Shock Master 300

Intervention Type DEVICE

Extracorporeal Shock Wave Therapy

In all treatments (from 1 to 10) applied number of pulses is 4500 and the frequency is based on the patients feelings (from 8 to 12 Hz). Variable is the pressure:

Treatment 1 - 2,5 Bar; Treatment 2 - 2,6 Bar; Treatment 3 - 2,7 Bar; Treatment 4 - 2,8 Bar; Treatment 5 - 3,0 Bar; Treatment 6 - 3,2 Bar; Treatment 7 - 3,4 Bar; Treatment 8 - 3,6 Bar; Treatment 9 - 3,8 Bar; Treatment 10 - 4,0 Bar.

Each patient will also receive kinesiotherapy treatment that will consist of:

* eight-minute massage of posterior lower leg muscles
* plantar aponeurosis stretching

Group 2 - Body Wave

Patients treated with electric field diathermy three times a week for 5 weeks

Group Type ACTIVE_COMPARATOR

Skanlab 25 BODYWAVE

Intervention Type DEVICE

Electric field diathermy therapy - Capacitive energy transfer system (CETS)

Time of each treatment (from 1 to 15) is eight minutes. Variable is the energy:

Treatment 1 - 3; Treatment 2 - 3; Treatment 3 - 4; Treatment 4 - 4; Treatment 5 - 5; Treatment 6 - 5; Treatment 7 - 6; Treatment 8 - 6; Treatment 9 - 7; Treatment 10 - 7; Treatment 11 - 7; Treatment 12 - 7; Treatment 13 - 7; Treatment 14 - 7; Treatment 15 - 7.

Each patient will also receive kinesiotherapy treatment that will consist of:

* eight-minute massage of posterior lower leg muscles
* plantar aponeurosis stretching

Group 3 - Ultrasound

Patients treated with ultrasound therapy three times a week for 5 weeks

Group Type ACTIVE_COMPARATOR

EVO US13 CosmoGamma

Intervention Type DEVICE

Ultrasound therapy

Doses applied as following:

Each treatment (from 1 to 15) is pulsed ultrasound (1MHz, pulsed 1:4). Variable is the time and intensity:

Treatment 1 - 4 minutes, 0,4 W/cm2; Treatment 2 - 5 minutes, 0,4 W/cm2; Treatment 3 - 5 minutes, 0,5 W/cm2; Treatment 4 - 6 minutes, 0,5 W/cm2; Treatment 5 - 6 minutes, 0,6 W/cm2; Treatment 6 - 6 minutes, 0,6 W/cm2; Treatment 7 - 6 minutes, 0,6 W/cm2; Treatment 8 - 6 minutes, 0,7 W/cm2; Treatment 9 - 7 minutes, 0,7 W/cm2; Treatment 10 - 7 minutes, 0,7 W/cm2; Treatment 11 - 7 minutes, 0,8 W/cm2; Treatment 12 - 8 minutes, 0,8 W/cm2; Treatment 13 - 8 minutes, 0,8 W/cm2; Treatment 14 - 8 minutes, 0,8 W/cm2; Treatment 15 - 8 minutes, 0,8 W/cm2.

Each patient will also receive kinesiotherapy treatment that will consist of:

* eight-minute massage of posterior lower leg muscles
* plantar aponeurosis stretching

Group 4 - Control group

Patients treated with sham laser therapy three times a week for 5 weeks

Group Type SHAM_COMPARATOR

Sham LASER CTL1106MX

Intervention Type DEVICE

Sham laser therapy Time of each treatment (from 1 to 15) is four to five minutes. Developed is 10 points, each point takes 15 seconds. Device is unplugged and it does not emit any radiation.The patient does not know that the procedure is not really executed.

Each patient will also receive kinesiotherapy treatment that will consist of:

* eight-minute massage of posterior lower leg muscles
* plantar aponeurosis stretching

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Shock Master 300

Extracorporeal Shock Wave Therapy

In all treatments (from 1 to 10) applied number of pulses is 4500 and the frequency is based on the patients feelings (from 8 to 12 Hz). Variable is the pressure:

Treatment 1 - 2,5 Bar; Treatment 2 - 2,6 Bar; Treatment 3 - 2,7 Bar; Treatment 4 - 2,8 Bar; Treatment 5 - 3,0 Bar; Treatment 6 - 3,2 Bar; Treatment 7 - 3,4 Bar; Treatment 8 - 3,6 Bar; Treatment 9 - 3,8 Bar; Treatment 10 - 4,0 Bar.

Each patient will also receive kinesiotherapy treatment that will consist of:

* eight-minute massage of posterior lower leg muscles
* plantar aponeurosis stretching

Intervention Type DEVICE

Skanlab 25 BODYWAVE

Electric field diathermy therapy - Capacitive energy transfer system (CETS)

Time of each treatment (from 1 to 15) is eight minutes. Variable is the energy:

Treatment 1 - 3; Treatment 2 - 3; Treatment 3 - 4; Treatment 4 - 4; Treatment 5 - 5; Treatment 6 - 5; Treatment 7 - 6; Treatment 8 - 6; Treatment 9 - 7; Treatment 10 - 7; Treatment 11 - 7; Treatment 12 - 7; Treatment 13 - 7; Treatment 14 - 7; Treatment 15 - 7.

Each patient will also receive kinesiotherapy treatment that will consist of:

* eight-minute massage of posterior lower leg muscles
* plantar aponeurosis stretching

Intervention Type DEVICE

EVO US13 CosmoGamma

Ultrasound therapy

Doses applied as following:

Each treatment (from 1 to 15) is pulsed ultrasound (1MHz, pulsed 1:4). Variable is the time and intensity:

Treatment 1 - 4 minutes, 0,4 W/cm2; Treatment 2 - 5 minutes, 0,4 W/cm2; Treatment 3 - 5 minutes, 0,5 W/cm2; Treatment 4 - 6 minutes, 0,5 W/cm2; Treatment 5 - 6 minutes, 0,6 W/cm2; Treatment 6 - 6 minutes, 0,6 W/cm2; Treatment 7 - 6 minutes, 0,6 W/cm2; Treatment 8 - 6 minutes, 0,7 W/cm2; Treatment 9 - 7 minutes, 0,7 W/cm2; Treatment 10 - 7 minutes, 0,7 W/cm2; Treatment 11 - 7 minutes, 0,8 W/cm2; Treatment 12 - 8 minutes, 0,8 W/cm2; Treatment 13 - 8 minutes, 0,8 W/cm2; Treatment 14 - 8 minutes, 0,8 W/cm2; Treatment 15 - 8 minutes, 0,8 W/cm2.

Each patient will also receive kinesiotherapy treatment that will consist of:

* eight-minute massage of posterior lower leg muscles
* plantar aponeurosis stretching

Intervention Type DEVICE

Sham LASER CTL1106MX

Sham laser therapy Time of each treatment (from 1 to 15) is four to five minutes. Developed is 10 points, each point takes 15 seconds. Device is unplugged and it does not emit any radiation.The patient does not know that the procedure is not really executed.

Each patient will also receive kinesiotherapy treatment that will consist of:

* eight-minute massage of posterior lower leg muscles
* plantar aponeurosis stretching

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

produced by GYMNA produced by SKANLAB AS produced by EMILDUE produced by CTL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* heel spur (calcaneal spur) diagnosed by a doctor based on X-ray examination, diagnostic ultrasonography or MR
* signed informed consent
* heel pain for at least one month

Exclusion Criteria

* pregnancy
* generalized acute infection (fever, cough, runny nose)
* local infection in the treated leg (wound, swelling)
* cancer
* injections of corticosteroids in the last six weeks
* pacemaker
* acute inflammation of the joints of the lower limbs
* inflammation of the veins
* Fresh fractures, post-traumatic
* osteoporosis
* Reynaud's disease
* Burger disease
* atherosclerosis
* after surgery condition before removing stitches
* High blood pressure
* after CT with contrast condition in the last two weeks
* The state of the lumbar puncture
* Strong imbalance
* Condition after myocardial infarction in the last six weeks
* Rheumatoid arthritis
* Ankylosing spondylitis
* Significant leg ulcers
* diabetes
* The risk of bleeding in the muscle tissue
* Thromboangiitis
* Hypersensitivity skin in the treated section
* A tendency to hemorrhage
* Pathological arrogance bone under the skin in the treated section
* Metal implants and surgical implants in the area of the lower limb subjected to therapy
Minimum Eligible Age

40 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medical University of Lodz

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Natalia Kociuga

Master of Physical Therapy

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Natalia Kociuga, master

Role: PRINCIPAL_INVESTIGATOR

Medical University of Lodz, Poland

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Non-public health care facility "NZOZ Komed"

Lodz, Łódź Voivodeship, Poland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Poland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Natalia Kociuga, master

Role: CONTACT

+48609018609

Marta Woldańska-Okońska, professor

Role: CONTACT

+48662130860

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Natalia Kociuga, master

Role: primary

+48609018609

Marta Woldańska-Okońska, Professor

Role: backup

+48662130860

Related Links

Access external resources that provide additional context or updates about the study.

http://czyrny.pl/pdf/Art_01_czyrny.JOTSRR.2.2010.pdf

review article describing what the "heel spurs" really are and what are their consequences

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RNN/47/16/KE

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.